
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ARK-3 CRISPR/Cas9 KO Plasmid (m) | sc-423193 | 20 µg | $397.00 |
Aurkc encodes Aurora kinase C (ARK-3), a serine/threonine kinase that regulates chromosome dynamics and cell division through phosphorylation of mitotic substrates involved in centrosome function, spindle assembly, and cytokinesis. In mouse germ cells, AURKC activity is particularly important for meiotic progression and accurate chromosomal segregation, intersecting with core mitotic regulatory networks that coordinate kinetochore–microtubule attachments and the spindle checkpoint. Dysregulation of Aurora kinase signaling is linked to aneuploidy and genomic instability, processes that are frequently studied in reproductive biology, developmental genetics, and cancer-relevant cell cycle models. Aurkc perturbation therefore provides a useful entry point for dissecting mechanisms of chromosome mis-segregation and cell cycle control.
ARK-3 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Aurkc gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Aurkc together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Aurkc open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ARK-3 protein expression.
This CRISPR knockout system enables efficient generation of Aurkc-deficient cell models for investigation of ARK-3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.